Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019;15(7-8):1929-1934.
doi: 10.1080/21645515.2018.1526559. Epub 2018 Nov 5.

Otolaryngologists and their role in vaccination for prevention of HPV associated head & neck cancer

Matthew Shew  1 , Marcia L Shew  2 , Andrés M Bur  1
Affiliations

Otolaryngologists and their role in vaccination for prevention of HPV associated head & neck cancer

Matthew Shew et al. Hum Vaccin Immunother. 2019.

Abstract

As Otolaryngologists we have witnessed a rise in a new disease with human papilloma virus (HPV) associated oropharyngeal squamous cell carcinoma (OPSCC). As of 2018, HPV associated OPSCC has surpassed the incidence of HPV associated cervical cancer within the United States. Non-HPV related head and neck cancer is largely a preventable disease through avoidance of various environmental factors, and we have seen a significant decline in cancer rates through anti-tobacco campaigns and other public health efforts. Given the success of HPV vaccination campaigns and reduction in HPV associated cervical and other anogenital cancers, some would argue HPV OPSCC is largely a preventable disease through vaccination as well. The question remains is how do we as otolaryngologist, non-primary care providers yet surgeons for this disease, help to promote public health efforts to reduce HPV related OPSCC. Within this article, we discuss preliminary data that supports HPV vaccination with HPV related OPSCC and the ongoing needs by our profession to help support public efforts in reducing the burden of this HPV related cancer.

Keywords: ENT; HPV; Oropharyngeal Cancer; Vaccination.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, Razzaghi H, Saraiya M.. Human papillomavirus-associated cancers - United States, 2008-2012. MMWR Morbid Mortal Weekly Rep. 2016;65(26):661–666. doi:10.15585/mmwr.mm6526a1. - DOI - PubMed
    1. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294–4301. doi:10.1200/JCO.2011.36.4596. - DOI - PMC - PubMed
    1. Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M, Lindquist D, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer. 2009;125(2):362–366. doi:10.1002/ijc.24339. - DOI - PubMed
    1. How Many Cancers Are Linked with HPV Each Year? [accessed 2018 July27] https://www.cdc.gov/cancer/hpv/statistics/cases.htm.
    1. D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944–1956. doi:10.1056/NEJMoa065497. - DOI - PubMed